RxDoctor Payments Data

Daniel Curtis, PA

Physician Assistant · Murrieta, CANPI 1013568773

Payments from drug & device makers

$1,338in general payments, 2019–2025

Across 78 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$303
  • Merck$210
  • AstraZeneca$143
  • Novo Nordisk$136
  • Pfizer$116
  • Amgen$92
  • plus $338 from 10 others

What the payments were for

  • Food & beverage$1,27395%
  • Education$655%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,338 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$24,156
Medicare patients
164
Services billed
347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban171$191,488
XareltoRivaroxaban88$65,276
EntrestoSacubitril/Valsartan70$61,993
JardianceEmpagliflozin21$22,363
FarxigaDapagliflozin Propanediol14$8,819
Ranolazine ErRanolazine91$6,059
Metoprolol Succinate161$2,229
Dabigatran EtexilateDabigatran Etexilate Mesylate11$2,060
Isosorbide Mononitrate ErIsosorbide Mononitrate141$1,812
Carvedilol217$1,732
Atorvastatin Calcium142$1,572
Losartan Potassium168$1,350
Nitroglycerin127$1,020
ClopidogrelClopidogrel Bisulfate82$999
Rosuvastatin Calcium36$796

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$116$191,488171 claims
Johnson & JohnsonXarelto$31$65,27688 claims
NovartisEntresto$33$61,99370 claims
Boehringer IngelheimJardiance$44$22,36321 claims
AstraZenecaFarxiga$143$8,81914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Murrieta

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →